Cutting edge drug developed in Oklahoma
OKLAHOMA CITY — Selexys Pharmaceuticals in Oklahoma City received a $25 million investment for a drug that treats Sickle Cell…
OKLAHOMA CITY — Selexys Pharmaceuticals in Oklahoma City received a $25 million investment for a drug that treats Sickle Cell…